Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mollipect
- Development stage
- Unknown
- Lead developer
- Karo Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Mollipect** is a combination oral solution containing **bromhexine hydrochloride** and **ephedrine hydrochloride**, used to treat cough associated with viscous mucus, particularly when bronchodilation is also needed. Bromhexine acts as a mucolytic agent, thinning mucus in the airways to facilitate expectoration by increasing serous bronchial secretion and supporting ciliary transport; it also exhibits antioxidant properties. Ephedrine, a sympathomimetic amine, functions as a bronchodilator by dilating airways and reducing mucous membrane swelling. Marketed primarily in Nordic countries and parts of Europe as a prescription medicine, it is produced by companies including Karo Healthcare and BioPhausia.
- Brand names
- Mollipect
02
Targets
MOR (Mu opioid receptor)AR (Adrenergic receptors)SMPD1 (Acid sphingomyelinase)MUC2 (Mucin-2)
Beyond the preview
Go deeper on Mollipect.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mollipect.